Internal Medicine, The University of Texas Rio Grande Valley School of Medicine, Edinburg, Texas, USA
Rheumatology Institute at Doctors Hospital at Renaissance, Edinburg, Texas, USA.
BMJ Case Rep. 2022 Nov 1;15(11):e249912. doi: 10.1136/bcr-2022-249912.
Organising pneumonia (OP) is a form of interstitial pneumonia characterised by inflammation and scarring leading to obstruction within the small airways and alveoli. Practice guidelines recommend treatment of moderate to severe OP with glucocorticoids; however, there have been cases of steroid-resistant OP successfully treated with rituximab. We describe a case of a woman in her 20s with rheumatoid arthritis who presented with pleuritic chest pain, haemoptysis and dyspnoea on exertion and was diagnosed with OP after multiple radiographic images and biopsies. The patient failed numerous treatment regimens, including corticosteroids, antibiotics and mycophenolate, but was successfully treated with rituximab. This case highlights the importance of identifying new therapeutic agents that will minimise the use of glucocorticoids in the treatment of OP.
机化性肺炎(OP)是一种间质性肺炎,其特征为炎症和瘢痕形成,导致小气道和肺泡内阻塞。临床实践指南建议使用糖皮质激素治疗中重度 OP;然而,已有使用利妥昔单抗成功治疗类固醇耐药性 OP 的病例报道。我们描述了一位 20 多岁的女性类风湿关节炎患者,她因胸膜炎性胸痛、咯血和活动后呼吸困难就诊,经过多次影像学检查和活检后被诊断为 OP。该患者对多种治疗方案(包括皮质类固醇、抗生素和霉酚酸酯)均无反应,但利妥昔单抗治疗成功。该病例强调了确定新的治疗药物的重要性,这些药物将最大限度地减少糖皮质激素在 OP 治疗中的使用。